A committee has recommended an expansion of the indication for Winrevair, an approved injection therapy for adults with PAH, ...
Columnist Jolie Lizana writes about techniques she uses to keep bad feelings at bay and remember the good moments in her life ...
The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and ...
Constantly being attached to home medical devices is overwhelming, but columnist Anna Jeter is also grateful for the ...
Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new ...
What is Adcirca for pulmonary arterial hypertension? Adcirca (tadalafil) is a once-daily oral therapy approved in the U.S. to improve exercise ability in people with pulmonary arterial hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback